The latest psychedelic drug company to commence public trading is Psyched Wellness.
Exploring the companies and themes that make up this emerging and exciting new sector
Mind Cure’s New Medtech Platform Is A Critical Puzzle-Piece
With its new digital therapeutics platform, Mind Cure is positioning itself as an emerging leader in the psychedelic drug industry.
Mind Cure Announces LOI for Acquisition of Epiphany360 Digital Therapeutics Platform for Treating Mental Health
Mind Cure has acquired Epiphany360, a digital therapeutics platform for the treatment of mental health conditions.
Cybin and Clarmin Announce Closing of CDN$45 Million Oversubscribed Private Placement and Provide Update on RTO
Cybin Corp. announces it has closed on an oversubscribed private placement of CAD$45 million as it prepares to go public.
Will MindMed NASDAQ Listing Be The Next Sector-Wide Catalyst?
The Compass Pathways IPO was a huge catalyst for the whole sector. Will a MindMed up-listing have the same impact?
How Medtech Is Taking Healthcare Into The 21st Century
What is medtech? It's the wave of the future for healthcare.
Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange
Mydecine begins the dual listing process to obtain an LSE listing.
Mind Cure Health : Announces Geoff Belair as Chief Technology Officer
Mind Cure brings in an expert in fintech to be its new CTO.
The 8 Best Reasons To Invest In Psychedelic Stocks
Acute need. Huge markets. A wide-open playing field. Those are some of the best reasons to invest in psychedelic drug stocks.
Numinus Appoints Multidisciplinary Global Leaders to its General Advisory Council
Numinus rolls out the list of Advisors on its psychedelics Advisory Council
Heroic Hearts Project and Field Trip Health Ltd. enter into a strategic relationship to increase legal psychedelic therapy access for military veterans in North America
Field Trip's new strategic partnership will facilitate bringing its ketamine-assisted psychotherapy for PTSD to military veterans.
Numinus (CSE:NUMI) or Mydecine (CSE:MYCO)? Two Psychedelics Investing Options
Both Numinus and Mydecine have been rising recently on big volume. Which is the better bet?